Clinical Trial Update: Biomarker Study: Heart Failure Patients at Risk [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 biomarker study in heart failure patients at risk, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University of Arizona | Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III | Phase 1, Phase 2 | Status: UNKNOWN